Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
09/13/2006 | EP1343486B1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
09/13/2006 | EP1303295B1 Caseinoglycomacropeptide for inhibiting adhesion of the pathogenic flora of the skin |
09/13/2006 | EP1286655B1 Topical composition containing at least one aryl oxime, and method for the preparation thereof |
09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
09/13/2006 | EP1242045B1 Use of an extract of at least one vaccinium-type plant as an anti-glycation agent |
09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
09/13/2006 | EP1200040B8 Two-component composition for cosmetic or pharmaceutical use |
09/13/2006 | EP1196579B1 Tryptase inhibitor |
09/13/2006 | EP1095062B1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
09/13/2006 | EP1079807B1 Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract |
09/13/2006 | EP0965340B1 Dermatologic preparation |
09/13/2006 | CN1830950A Method synthesizing arotinoid acid and arotinoid ethylester, and its pharmaceutical application |
09/13/2006 | CN1830314A Health-care food for anti oxidation and improving sleep |
09/13/2006 | CN1274710C New triterpene compound 3 beta-(counter) ferulic acid group lupeol and preparation method thereof |
09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
09/13/2006 | CN1274668C Salts of nateglinide |
09/13/2006 | CN1274667C Cycloalkenone derivative |
09/13/2006 | CN1274350C Combination of medication for curing burn and scald and preparation method |
09/13/2006 | CN1274348C Production process of hair restorer bolus |
09/13/2006 | CN1274331C Mixture for treating acute condyloma |
09/13/2006 | CN1274323C Wind expelling, toxin removing bone reaching powder |
09/13/2006 | CN1274315C Nutrient fluid for treating ultraviolet allergy |
09/13/2006 | CN1274291C Compositions and methods for treating hyperpigmentation |
09/13/2006 | CN1274243C Hair tonic amino acid and its preparation method |
09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
09/12/2006 | US7105577 Antimicrobial method using a hydroxydiphenyl ether compound |
09/12/2006 | US7105573 Administering to the mammal an insulin sensitivity increasing substance (ISIS) in an amount effective to treat the disorder in the mammal, in a manner so as to reach an affected area of the pilosebaceous apparatus |
09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
09/12/2006 | US7105508 Integrin receptors antagonists |
09/12/2006 | US7105490 Methods and compositions for treating polycystic ovary syndrome |
09/12/2006 | US7105489 Methods and compositions for treating polycystic ovary syndrome |
09/12/2006 | US7105485 HO-1 suppressor as a diagnostic and prognostic test for dementing diseases |
09/12/2006 | US7105188 Fermentation solution of a sugar component, water, and a pine leaf cluster; allowing fermentation solution to stand for a period of time; treating atopic dermatitis and athlete's foot |
09/12/2006 | US7105184 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant Argania spinosa |
09/12/2006 | CA2406680C Topical anti-acne composition |
09/12/2006 | CA2366705C Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields |
09/12/2006 | CA2120531C Dermatologic and/or cosmetic composition containing retinoidic compounds |
09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
09/08/2006 | WO2006093313A1 T cell apoptosis inducer |
09/08/2006 | WO2006093291A1 19-norvitamin d derivative |
09/08/2006 | WO2006093267A1 Fermentation composition having immunomodulating effect |
09/08/2006 | WO2006093253A1 Novel cyclic compound having quinolylalkylthio group |
09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
09/08/2006 | WO2006093226A1 Antipruritic agent |
09/08/2006 | WO2006093202A1 Phloroacylphenone glycoside, process for production of the same, antiallergic agent and antioxidant |
09/08/2006 | WO2006092580A1 Combination therapy |
09/08/2006 | WO2006092507A1 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
09/08/2006 | WO2006092017A1 Glycoalkaloid and tlr agonist combinations and various uses thereof |
09/08/2006 | WO2006063811A3 Substituted 1,2,4-triazin-5(2h)-ones |
09/08/2006 | WO2006044878A3 A reinforced absorbable multilayered fabric for use in tissue repair and regeneration |
09/08/2006 | CA2600287A1 Use of cinnamoyl compound |
09/08/2006 | CA2600118A1 Fermented compositions having immunomodulatory actions |
09/08/2006 | CA2599848A1 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
09/08/2006 | CA2599544A1 Novel aminopyridine compound with syk inhibitory activity |
09/08/2006 | CA2579888A1 Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
09/07/2006 | US20060200213 Method and apparatus for skin treatment |
09/07/2006 | US20060199957 Novel bicyclic and tricyclic cannabinoids |
09/07/2006 | US20060199859 Topical medicaments and methods for photodynamic treatment of disease |
09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
09/07/2006 | US20060199830 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds |
09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
09/07/2006 | US20060199815 NK1 antagonists |
09/07/2006 | US20060199791 Personal hygiene and hard surface cleaning agent; acne, skin complaints; effective against antibiotic resistant bacteria |
09/07/2006 | US20060199787 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
09/07/2006 | US20060199762 Skin ulcer preventive curative agent containing human recombinant hgf |
09/07/2006 | US20060198846 Combinations for the treatment of diseases involving angiogenesis |
09/07/2006 | DE102005033009A1 Pharmaceutical, dermatological or cosmetic preparation, useful e.g. sun protective cream and cleansing milk, comprises a part of aqueous phase or water of freshly prepared aqueous plant content |
09/06/2006 | EP1698695A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
09/06/2006 | EP1698623A1 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
09/06/2006 | EP1698337A1 Use of cyclic amine derivatives in capillary products |
09/06/2006 | EP1698333A1 Fulvic acid and its use in the treatment of viral infections |
09/06/2006 | EP1698320A1 Skin moisturizing agent for oral intake and functional foods and drinks |
09/06/2006 | EP1697355A2 Amidino compounds as cysteine protease inhibitors |
09/06/2006 | EP1696936A2 Cosmetic or pharmaceutical preparations containing nucleic acid sequences forming a superstructure |
09/06/2006 | EP1696908A1 Use of ondansetron for the treatment of inflammation, and pharmaceutical compositions thereof |
09/06/2006 | EP1696903A1 Combination of 2,3-dibenzylbutyrolactone and licochalcone-a |
09/06/2006 | EP1696868A1 Topical skin care composition containing refined peanut oil |
09/06/2006 | EP1458697B1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
09/06/2006 | EP1401275B1 Antiviral composition and treatment method |
09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
09/06/2006 | EP1341517B1 A skin cream composition |
09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
09/06/2006 | EP1286652B1 Skin protectant spray compositions |
09/06/2006 | EP1259241B8 The use of scopolamine salts |
09/06/2006 | CN1829496A Use of spermine and/or spermidine against skin ageting in dietary, pharmaceutical or cosmetic compositions |
09/06/2006 | CN1827766A In vitro cell cultivation method |